COMPARATIVE SENSITIVITY OF URINARY CYFRA 21-1, URINARY BLADDER CANCER ANTIGEN, TISSUE POLYPEPTIDE ANTIGEN AND NMP22 TO DETECT BLADDER CANCER-Reference-Cited by-同舟云学术

COMPARATIVE SENSITIVITY OF URINARY CYFRA 21-1, URINARY BLADDER CANCER ANTIGEN, TISSUE POLYPEPTIDE ANTIGEN AND NMP22 TO DETECT BLADDER CANCER

Published:1999-12 Issue:6 Volume:162 Page:1951-1956
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

SÁNCHEZ-CARBAYO MARTA¹,HERRERO ENRIQUE¹,MEGÍAS JULIÁN¹,MIRA ANTONIO¹,SORIA FEDERICO¹

Affiliation:

1. From the Laboratorio de Marcadores Tumorales, Servicios de Análisis Clínicos and Urologia, Hospital General Universitario de Alicante, Alicante, Spain

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference25 articles.

1. Preventing recurrence and progression in superficial bladder cancer;Newling;Curr. Opin. Urol.,1996

2. Bladder cancer: natural history, tumor markers and early detection strategies;Foresman;Sem. Surg. Oncol.,1997

3. Superficial bladder cancer: for how long should a tumor-free patient have check cystoscopies? Brit;Morris;J. Urol.,1995

4. The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma;Badalament;Cancer,1987

5. Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low grade superficial bladder tumors;Cordon-Cardo;Amer. J. Path.,1992

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accuracy of cytokeratin 19 fragment in the diagnosis of bladder cancer;Biomarkers in Medicine;2022-02

2. Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?;Translational Andrology and Urology;2021-06

3. Comparison of the diagnostic performance of fluorescence in situ hybridization (FISH), nuclear matrix protein 22 (NMP22), and their combination model in bladder carcinoma detection: a systematic review and meta-analysis;OncoTargets and Therapy;2018-12

4. Current Use and Promise of Urinary Markers for Urothelial Cancer;Current Urology Reports;2018-10-17

5. Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer;Expert Review of Molecular Diagnostics;2018-05-04